NOP53
Basic information
Region (hg38): 19:47745546-47757058
Previous symbols: [ "GLTSCR2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NOP53 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 71 | 73 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 71 | 2 | 3 |
Variants in NOP53
This is a list of pathogenic ClinVar variants found in the NOP53 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-47745564-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
19-47745566-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
19-47745570-G-A | not specified | Uncertain significance (Dec 12, 2024) | ||
19-47745592-G-T | not specified | Uncertain significance (Jan 02, 2024) | ||
19-47745596-A-C | not specified | Uncertain significance (Dec 05, 2024) | ||
19-47745671-C-G | not specified | Uncertain significance (Nov 24, 2024) | ||
19-47745675-G-C | not specified | Uncertain significance (Apr 07, 2022) | ||
19-47745677-G-A | not specified | Uncertain significance (Sep 10, 2024) | ||
19-47745691-G-C | not specified | Uncertain significance (Sep 14, 2023) | ||
19-47745726-T-C | not specified | Uncertain significance (Jun 07, 2024) | ||
19-47745731-C-G | not specified | Uncertain significance (Jun 07, 2024) | ||
19-47745746-T-C | not specified | Uncertain significance (Aug 04, 2023) | ||
19-47746986-C-G | not specified | Uncertain significance (Mar 06, 2023) | ||
19-47746989-A-C | not specified | Uncertain significance (Jan 27, 2025) | ||
19-47746989-A-G | not specified | Likely benign (Oct 25, 2024) | ||
19-47747020-C-G | not specified | Uncertain significance (Jun 07, 2023) | ||
19-47750183-A-G | not specified | Uncertain significance (Jun 19, 2024) | ||
19-47750197-C-G | Benign (Jan 25, 2018) | |||
19-47750238-G-A | not specified | Uncertain significance (Jul 31, 2024) | ||
19-47750247-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
19-47750264-T-C | not specified | Uncertain significance (Oct 24, 2024) | ||
19-47750276-G-T | not specified | Uncertain significance (Jan 16, 2025) | ||
19-47750277-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
19-47750915-G-A | not specified | Uncertain significance (Jul 07, 2024) | ||
19-47750915-G-T | not specified | Uncertain significance (Mar 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NOP53 | protein_coding | protein_coding | ENST00000246802 | 13 | 11537 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.181 | 0.818 | 125727 | 0 | 17 | 125744 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.647 | 306 | 276 | 1.11 | 0.0000182 | 2932 |
Missense in Polyphen | 84 | 82.507 | 1.0181 | 857 | ||
Synonymous | -1.99 | 152 | 124 | 1.23 | 0.00000827 | 997 |
Loss of Function | 3.40 | 6 | 24.0 | 0.250 | 0.00000115 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000246 | 0.000246 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.0000929 | 0.0000924 |
European (Non-Finnish) | 0.0000792 | 0.0000791 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Nucleolar protein which is involved in the integration of the 5S RNP into the ribosomal large subunit during ribosome biogenesis (PubMed:24120868). In ribosome biogenesis, may also play a role in rRNA transcription (PubMed:27729611). Also functions as a nucleolar sensor that regulates the activation of p53/TP53 in response to ribosome biogenesis perturbation, DNA damage and other stress conditions (PubMed:21741933, PubMed:24120868, PubMed:27829214). DNA damage or perturbation of ribosome biogenesis disrupt the interaction between NOP53 and RPL11 allowing RPL11 transport to the nucleoplasm where it can inhibit MDM2 and allow p53/TP53 activation (PubMed:24120868, PubMed:27829214). It may also positively regulate the function of p53/TP53 in cell cycle arrest and apoptosis through direct interaction, preventing its MDM2-dependent ubiquitin-mediated proteasomal degradation (PubMed:22522597). Originally identified as a tumor suppressor, it may also play a role in cell proliferation and apoptosis by positively regulating the stability of PTEN, thereby antagonizing the PI3K-AKT/PKB signaling pathway (PubMed:15355975, PubMed:16971513, PubMed:27729611). May also inhibit cell proliferation and increase apoptosis through its interaction with NF2 (PubMed:21167305). May negatively regulate NPM1 by regulating its nucleoplasmic localization, oligomerization and ubiquitin-mediated proteasomal degradation (PubMed:25818168). Thereby, may prevent NPM1 interaction with MYC and negatively regulate transcription mediated by the MYC-NPM1 complex (PubMed:25956029). May also regulate cellular aerobic respiration (PubMed:24556985). In the cellular response to viral infection, may play a role in the attenuation of interferon-beta through the inhibition of DDX58/RIG-1 (PubMed:27824081). {ECO:0000269|PubMed:15355975, ECO:0000269|PubMed:16971513, ECO:0000269|PubMed:21167305, ECO:0000269|PubMed:21741933, ECO:0000269|PubMed:22522597, ECO:0000269|PubMed:24120868, ECO:0000269|PubMed:24556985, ECO:0000269|PubMed:25818168, ECO:0000269|PubMed:25956029, ECO:0000269|PubMed:27729611, ECO:0000269|PubMed:27824081, ECO:0000269|PubMed:27829214}.;
- Pathway
- Herpes simplex infection - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.181
Intolerance Scores
- loftool
- rvis_EVS
- 0.4
- rvis_percentile_EVS
- 76.41
Haploinsufficiency Scores
- pHI
- 0.622
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.505
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Nop53
- Phenotype
- immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- ribosomal large subunit assembly;negative regulation of transcription by RNA polymerase II;regulation of protein phosphorylation;DNA repair;rRNA processing;cellular response to DNA damage stimulus;mitotic G2 DNA damage checkpoint;negative regulation of phosphatidylinositol 3-kinase signaling;negative regulation of protein complex assembly;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;regulation of RIG-I signaling pathway;regulation of apoptotic process;protein stabilization;regulation of cell cycle;negative regulation of protein kinase B signaling;cellular response to hypoxia;regulation of signal transduction by p53 class mediator;negative regulation of signal transduction by p53 class mediator;negative regulation of transcription of nucleolar large rRNA by RNA polymerase I;protein localization to nucleolus;positive regulation of protein K63-linked deubiquitination;regulation of aerobic respiration;protein localization to nucleoplasm
- Cellular component
- fibrillar center;nucleoplasm;nucleolus;cytosol;rDNA heterochromatin;intracellular membrane-bounded organelle
- Molecular function
- p53 binding;RNA binding;protein binding;5S rRNA binding;identical protein binding